Fountain Life, a preventative health and longevity company committed to transforming global healthcare from reactive to proactive, today announced it has secured $15M in funding from Eos Venture Partners, the leading InsurTech investor, and Newcross Healthcare, experts in healthcare including treatment and care at home, based in the United Kingdom. The investment is intended to support Fountain Life, including its integrated insurance business, to transform the healthcare ecosystem while improving future healthcare and its availability in the home and more widely around the globe.

Fountain Life brings together the world's most renowned scientists and physicians to boost longevity and performance - putting health back in healthcare. Fountain Life does this by using cutting-edge Artificial Intelligence (AI) to collect data and gain insights into the human body that have never been possible before. Fountain Life's data-driven approach enables finding illnesses, including cancer, cardiac, metabolic, and neurodegenerative disease, early before they can cause harm. As a result, Fountain Life members operate at peak performance throughout their life with the aim that they will feel as healthy and vibrant at 100 as they were at 60.